The US Bankruptcy Court gave an order approving the sale of substantially all the assets of Timber Pharmaceuticals, Inc. on January 22, 2024. The debtor has been authorized to sell substantially all its assets to LEO Spiny Merger Sub, Inc. and LEO Pharma A/S for a purchase price of $14.35 million in cash plus the assumption of the assumed liabilities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -83.33% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-83.33% | 617 | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- TMBRQ Stock
- News Trex Wind-down, Inc.
- Motion for Asset Sale Approved for Timber Pharmaceuticals, Inc.